Tritium

vascular endothelial growth factor A ; Homo sapiens







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33485105 Biphenylurea/thiourea derivatives tagged with heteroarylsulfonamide motifs as novel VEGFR2 inhibitors; Design, synthesis and anti-angiogenic activity. 2021 Feb 1
2 21282065 Interpretation of elevated serum VEGF concentrations in patients with myocardial infarction. 2011 Apr 1
3 15784655 YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models. 2005 Jul 2
4 15506488 [The effect of growth factors on the proliferation of cultured porcine trabecular meshwork cells]. 2004 Sep 1
5 11312104 Vascular endothelial growth factor-A activates Ca2+ -activated K+ channels in human endothelial cells in culture. 2001 Apr 1
6 11352660 Endogenous production of nitric oxide by vascular endothelial growth factor down-regulates proliferation of choriocarcinoma cells. 2001 Apr 13 1
7 11026652 Inhibition of vascular endothelial growth factor activity by transfection with the soluble FLT-1 gene. 2000 Oct 2
8 10331422 Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway. 1999 May 2
9 10698278 Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells. 1999 2
10 11776866 [Preparation of monoclonal antibodies to human vascular endothelial growth factor(VEGF121) and identification of its expression on gastric carcinoma cell line MGC803]. 1999 Mar 1
11 14517472 Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation. 1998 2
12 9277477 Hypoxia-induced expression of VEGF is reversible in myocardial vascular smooth muscle cells. 1997 Aug 1
13 8840857 Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. 1996 Oct 1 1
14 8841939 Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action. 1996 Jul 1
15 8304487 Glomerular endothelial cells in culture express and secrete vascular endothelial growth factor. 1994 Jan 3